home / stock / hrtx / hrtx quote
Last: | $2.87 |
---|---|
Change Percent: | 0.0% |
Open: | $2.77 |
Close: | $2.87 |
High: | $2.87 |
Low: | $2.7 |
Volume: | 1,602,958 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.87 | $2.77 | $2.87 | $2.87 | $2.7 | 1,602,958 | 07-05-2024 |
$2.77 | $2.75 | $2.77 | $2.885 | $2.7 | 1,865,822 | 07-04-2024 |
$2.77 | $2.75 | $2.77 | $2.885 | $2.7 | 1,865,822 | 07-03-2024 |
$2.74 | $3.45 | $2.74 | $3.47 | $2.71 | 7,518,647 | 07-02-2024 |
$3.47 | $3.52 | $3.47 | $3.615 | $3.44 | 1,197,864 | 07-01-2024 |
$3.5 | $3.46 | $3.5 | $3.55 | $3.35 | 8,612,107 | 06-28-2024 |
$3.41 | $3.32 | $3.41 | $3.475 | $3.26 | 1,159,273 | 06-27-2024 |
$3.33 | $3.07 | $3.33 | $3.34 | $3.01 | 1,610,241 | 06-26-2024 |
$3.05 | $3.2 | $3.05 | $3.25 | $3.03 | 1,296,474 | 06-25-2024 |
$3.18 | $3.23 | $3.18 | $3.31 | $3.13 | 1,418,575 | 06-24-2024 |
$3.23 | $3.31 | $3.23 | $3.43 | $3.18 | 5,573,926 | 06-21-2024 |
$3.29 | $3.39 | $3.29 | $3.48 | $3.27 | 1,354,398 | 06-20-2024 |
$3.42 | $3.22 | $3.42 | $3.515 | $3.22 | 1,594,580 | 06-19-2024 |
$3.42 | $3.22 | $3.42 | $3.515 | $3.22 | 1,594,580 | 06-18-2024 |
$3.225 | $3.6 | $3.225 | $3.605 | $3.21 | 2,864,847 | 06-17-2024 |
$3.6 | $3.58 | $3.6 | $3.71 | $3.56 | 1,314,544 | 06-14-2024 |
$3.635 | $3.68 | $3.635 | $3.75 | $3.575 | 1,091,377 | 06-13-2024 |
$3.66 | $3.78 | $3.66 | $3.93 | $3.6 | 1,300,914 | 06-12-2024 |
$3.64 | $3.67 | $3.64 | $3.72 | $3.45 | 1,645,130 | 06-11-2024 |
$3.69 | $3.6 | $3.69 | $3.72 | $3.555 | 1,114,306 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...
Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire SAN DIEGO , May 29, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechn...
2024-05-27 10:45:03 ET Heron Therapeutics Inc (HRTX) HRTX is trading UP for the last 5 days, and it at trading at $2.86 with volume of 6,916,602 and a one day change of $0.02 (0.53%). Heron Therapeutics Inc has a 52-week low of 0.50 and a 52-week high of $3.22. The business's 50-day...